These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16456880)
1. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. Verrills NM; Liem NL; Liaw TY; Hood BD; Lock RB; Kavallaris M Proteomics; 2006 Mar; 6(5):1681-94. PubMed ID: 16456880 [TBL] [Abstract][Full Text] [Related]
2. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia. Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783 [TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997 [TBL] [Abstract][Full Text] [Related]
4. A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts. Ong V; Liem NL; Schmid MA; Verrills NM; Papa RA; Marshall GM; Mackenzie KL; Kavallaris M; Lock RB J Pharmacol Exp Ther; 2008 Feb; 324(2):434-42. PubMed ID: 17986648 [TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. Verrills NM; Walsh BJ; Cobon GS; Hains PG; Kavallaris M J Biol Chem; 2003 Nov; 278(46):45082-93. PubMed ID: 12949081 [TBL] [Abstract][Full Text] [Related]
6. [Correlation of high expression of HSP27 to multidrug resistance of leukemia cell line K562/VCR]. Zhang ZX; Wen FQ; Liu ZP; Cheng YD Ai Zheng; 2008 Apr; 27(4):348-53. PubMed ID: 18423118 [TBL] [Abstract][Full Text] [Related]
7. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model. Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770 [TBL] [Abstract][Full Text] [Related]
8. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. Yang YX; Chen ZC; Zhang GY; Yi H; Xiao ZQ J Cell Biochem; 2008 Jun; 104(3):1010-21. PubMed ID: 18253933 [TBL] [Abstract][Full Text] [Related]
9. Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance. Besada V; Diaz M; Becker M; Ramos Y; Castellanos-Serra L; Fichtner I Proteomics; 2006 Feb; 6(3):1038-48. PubMed ID: 16385476 [TBL] [Abstract][Full Text] [Related]
10. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [TBL] [Abstract][Full Text] [Related]
11. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804 [TBL] [Abstract][Full Text] [Related]
12. [Screening proteins related to retinoic acid resistance by proteomic analysis]. Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200 [TBL] [Abstract][Full Text] [Related]
13. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard. Horton JK; Houghton PJ; Houghton JA Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432 [TBL] [Abstract][Full Text] [Related]
14. Effects of cytoskeletal inhibitors on the accumulation of vincristine in a resistant human lung cancer cell line with high level of polymerized tubulin. Chan MW; Chiang CD; Song EJ; Yang VC Cancer Biochem Biophys; 1998 Nov; 16(4):347-63. PubMed ID: 9925282 [TBL] [Abstract][Full Text] [Related]
15. Cytoskeleton changes following differentiation of N1E-115 neuroblastoma cell line. Oh JE; Karlmark Raja K; Shin JH; Pollak A; Hengstschläger M; Lubec G Amino Acids; 2006 Oct; 31(3):289-98. PubMed ID: 16547650 [TBL] [Abstract][Full Text] [Related]
16. Application of saturation dye 2D-DIGE proteomics to characterize proteins modulated by oxidized low density lipoprotein treatment of human macrophages. Dupont A; Chwastyniak M; Beseme O; Guihot AL; Drobecq H; Amouyel P; Pinet F J Proteome Res; 2008 Aug; 7(8):3572-82. PubMed ID: 18549265 [TBL] [Abstract][Full Text] [Related]
17. Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Shen DW; Liang XJ; Gawinowicz MA; Gottesman MM Mol Pharmacol; 2004 Oct; 66(4):789-93. PubMed ID: 15385639 [TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis. Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680 [TBL] [Abstract][Full Text] [Related]
19. Early osteogenic differential protein profile detected by proteomic analysis in human periodontal ligament cells. Wu L; Wei X; Ling J; Liu L; Liu S; Li M; Xiao Y J Periodontal Res; 2009 Oct; 44(5):645-56. PubMed ID: 19453858 [TBL] [Abstract][Full Text] [Related]
20. Proteomics strategy based on liquid-phase IEF and 2-D DIGE: application to bone marrow mesenchymal progenitor cells. Seshi B Proteomics; 2007 Jun; 7(12):1984-99. PubMed ID: 17516591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]